SciELO - Scientific Electronic Library Online

vol.59 número2Rob(13; 15) (q10; q10) translocation: comments on a caseRisk Factors Associated With Persistent Arthralgia In Chikungunya Virus-Infected Patients - A Systematic Review índice de autoresíndice de assuntospesquisa de artigos
Home Pagelista alfabética de periódicos  

Serviços Personalizados



Links relacionados

  • Em processo de indexaçãoCitado por Google
  • Não possue artigos similaresSimilares em SciELO
  • Em processo de indexaçãoSimilares em Google


Universitas Medica

versão impressa ISSN 0041-9095
versão On-line ISSN 2011-0839


CORTES HIDALGO, Andrea Patricia; ROA DUENAS, Oscar Hernando; MENDEZ FANDINO, Yardany Rafael  e  ALVAREZ-MORENO, Carlos A.. Therapeutic Options in the Management of Echinocandin Resistant Candida Species. Univ. Med. [online]. 2018, vol.59, n.2, pp.37-51. ISSN 0041-9095.


Candida yeasts infections represent the most common cause of invasive fungal infections. Its high incidence and increasing resistance to azoles and, recently, to echinocandins has generated the need to find new therapeutic options. This review presents the main pharmacological alternatives in research against echinocandins resistant Candida.


A search was conducted in the databases of Bireme, Clinical Key, Embase, Cochrane, Lilacs, Pubmed and Scopus. 15 articles were included in this review.


Several alternatives are explored, including increased doses of echinocandins, combination with other drugs and new compounds under study.


Although resistant Candida infections still represent a challenge, two pharmacological approaches show promise: The combination with existing medicaments such as diclofenac, and new compounds that are currently in Phase II of clinical trials.

Palavras-chave : echinocandins; Candida; drug resistance; fungal; antifungal agents.

        · resumo em Espanhol     · texto em Espanhol     · Espanhol ( pdf )